drug prices

When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized.  The price of the autoinjector used for severe allergic reactions was hiked by about 500 percent between 2007 and 2016.  Both Democrats and Republicans came out strongly against...

The Food and Drug Administration announced Monday it would publish correspondence with drug manufacturers accused of abusing agency standards to foil generic competitors. Height Capital Markets considers the public censuring indicative of a broader federal strategy to pressure industry change....

President Donald Trump has nominated Alex Azar, a former pharmaceutical executive, to run the Department of Health and Human Services. What You Need To Know The Department of Health and Human Services is a cabinet-level department of the U.S. federal government with a mission of protecting...

As was widely documented, the healthcare sector languished last year thanks in large part to presidential election rhetoric in which both candidates excoriated biotechnology and pharmaceuticals for high drug prices. The Health Care SPDR (ETF) (NYSE: XLV), the largest healthcare exchange-traded fund...

President Donald Trump said Tuesday that drug prices are "astronomical" and much needed change needs to be implemented. His comments come at a time when he hosted drug makers at the White House and are also consistent with promises he made both during and after the campaign trail....

Perhaps the only thing that traders can know for certain about President-elect Donald Trump’s policy decisions is that they should always expect the unexpected. Biotech investors thought they had scored a major victory in November when Trump defeated Hillary Clinton. Clinton had made...

Shares of Express Scripts Holding Company (NASDAQ: ESRX) fell more than 6 percent on Wednesday after the company announced its 2017 financial guidance and hosted a conference call to discuss its outlook. Citron On The Offense Notable short seller Citron Research likened Express Scripts last week as...

Pharmaceutical companies breathed a sigh of relief when Donald Trump prevailed on Election Day. His opponent, Hillary Clinton, had made prescription drug pricing a centerpiece of her campaign. However, according to Bernstein analyst Tim Anderson, pharma stocks may not be off the hook when Trump...

It is the second-largest sector weight in the S&P 500 and also the worst-performing corner of the benchmark U.S. equity gauge this year, but with Election Day finally here, it is possible the worst is behind the healthcare space. The Health Care SPDR (ETF) (NYSE: XLV), the largest healthcare...